5-HT1B receptor subtype and aging in rat resistance vessels

Guglielmina Froldi1, Monica Montopoli, Miriam Zanetti

  • 1Department of Pharmacology and Anaesthesiology, University of Padova, Padova, Italy. g.froldi@unipd.it

Pharmacology
|October 6, 2007
PubMed

Insights

Aging enhances the

Area of Science:

  • Pharmacology
  • Neuroscience
  • Cardiovascular Research

Background:

  • The 5-hydroxytryptamine (5-HT) system plays a crucial role in vascular function.
  • The 5-HT(1B) receptor subtype is often considered 'silent' due to low basal activity.
  • Understanding factors that enhance 5-HT(1B) receptor activity is key for therapeutic development.

Purpose of the Study:

  • To identify experimental conditions that enhance the activity of the 'silent' 5-HT(1B) receptor subtype.
  • To investigate the influence of aging on 5-HT receptor function in rat caudal arteries.
  • To establish a pharmacological model for studying the 5-HT(1B) receptor.

Main Methods:

  • Vascular responses to 5-HT receptor agonists (5-HT, 5-carboxamidotryptamine, sumatriptan) were measured in rat caudal arteries.
  • Experimental conditions included reserpine treatment and potassium (K+) depolarization.
  • Selective receptor antagonists (ritanserin for 5-HT(2A), SB-224289 for 5-HT(1B)) and RT-PCR were employed.

Main Results:

  • Reserpine treatment and K+ depolarization significantly increased vasoconstriction mediated by 5-HT receptor agonists.
  • Aging shifted the concentration-vasoconstriction curve for sumatriptan, increasing maximal contractile response, particularly in reserpine-treated tissues.
  • RT-PCR confirmed age-related changes in 5-HT(1B) and 5-HT(2A) receptor expression.

Conclusions:

  • Reserpine-treated and K+-depolarized caudal arteries from aged rats provide a valuable model for studying the 'silent' 5-HT(1B) receptor.
  • Aging significantly modulates the functional expression and responsiveness of the 5-HT(1B) receptor.
  • These findings have implications for understanding age-related vascular changes and developing targeted therapies.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...